Differentiating cytology of pancreatic ductal adenocarcinoma and pancreatic neuroendocrine tumors by EUS-FNA through hyperspectral imaging technology combined with artificial intelligence
Therapeutic Advances in Gastroenterology
Published online on January 14, 2026
Abstract
Therapeutic Advances in Gastroenterology, Volume 19, January-December 2026.
Background:Pancreatic cancer is a common and lethal malignancy, with the two primary subtypes being pancreatic ductal adenocarcinoma (PDAC) and pancreatic neuroendocrine tumors (pNET). Accurate diagnosis and effective treatment are crucial. Hyperspectral ...
Background:Pancreatic cancer is a common and lethal malignancy, with the two primary subtypes being pancreatic ductal adenocarcinoma (PDAC) and pancreatic neuroendocrine tumors (pNET). Accurate diagnosis and effective treatment are crucial. Hyperspectral ...